Clarification on Salary Supplementation and Compensation During - - PowerPoint PPT Presentation

Clarification on Salary Supplementation and Compensation During Entire Period of K Award

1

25% 75%

100 % Full-Time Professional Percent Effort

75% minimum devoted to K award (50% minimum for certain clinical specialties). Salary supplementation must be from non- Federal source 25% not devoted to K

• award. Salary

compensation may be from Federal grant or non-Federal source

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-094.html

ORCD Achieving Research Independence, P. Kay Lund, PhD

Reduced Effort, Salary Supplementation and Compensation During Last 2 yrs of K Award

2

25% 25% 50%

100 % Full-Time Professional Percent Effort

50% minimum devoted to K award. Salary supplementation must be from non- Federal source 25% not devoted to K

• award. Salary

compensation may be from Federal grant or non-Federal source 25% research and Salary compensation

• nly if PD/PI on

Federal grant

ORCD Achieving Research Independence, P. Kay Lund, PhD

Rigor & Reproducibility Updates

ORCD Achieving Research Independence, P. Kay Lund, PhD

3

NIH Weekly Table of Contents

• Useful way to receive weekly emails (usually on Friday

afternoon) with the Current Weekly Table of Contents (TOC) from the NIH Guide to Grants and Contracts

• Direct links to all funding opportunities and notices

published during each week

• Information on new programs & RFAs
• Many early stage investigators do not access

https://grants.nih.gov/Grants/guide/listserv.htm

NIH Guide LISTSERV: Subscribe to Weekly TOC E-Mail with New NIH Guide Postings

ORCD Achieving Research Independence, P. Kay Lund, PhD

4

Congress & the NIH Next Generation Researcher Initiative (NGRI)

5 “The Director of the National Institutes of Health shall … develop, modify, or prioritize policies, as needed … to promote opportunities for new researchers and earlier research independence, such as policies to increase opportunities for new researchers to receive funding, enhance training and mentorship programs for researchers, and enhance workforce diversity.”

ORCD Achieving Research Independence, P. Kay Lund, PhD

Updates on NIH Next Generation Researchers Initiative (NGRI)

• Presented at June 2017 NIH Advisory Committee to the NIH

Director (ACD)

• NIH Guide notice (NOT-OD-17-101) published August 31, 2017:

Policy Supporting the Next Generation Researchers Initiative

• Enhance support for Early Stage Investigators
• Being refined with feedback from NIH leadership, and ongoing

input from an NGRI ACD working group

• Input from an NIH supported National Academies of Sciences,

Engineering and Medicine (NASEM) NGRI study anticipated in April 2018.

6

ORCD Achieving Research Independence, P. Kay Lund, PhD

Early Stage Investigators

• Early stage investigator or ESI is a Program Director/Principal

Investigator (PD/PI) who has completed their terminal research degree or end of post-graduate clinical training **, whichever date is later, within the past 10 years and who has not previously competed successfully as PD/PI for a substantial NIH independent research award.

• Multiple PI grants: ALL must be ESI to qualify for ESI status

Ensure ESI status is up to date **Clinicians should update their eRA commons profile if it currently has the end date of medical residency and provide the end date of postgraduate clinical training including fellowship.**

7

ORCD Achieving Research Independence, P. Kay Lund, PhD

Questions re gender & funding

• Funding rates for women (22.3%) and men (23.9%) similar in

2016

• Between 2009 and 2016 R01 applications from women

increased by 96.4% while those from men increased by 49.7%

• In the same period R01 awards to women increased by 69.4%

while those to men increased by 25.8%

• Age to first R01 and renewal is similar for men and women
• R01 applicants between 2009-16: women represent 37.9% of

ESI applicants, 32.1% of New Investigators (NI) & 27.2% of established investigators

• R01 awardees: women 36.2% ESI, 33.9% NI and 26.5%

established investigators

8

ORCD Achieving Research Independence, P. Kay Lund, PhD

Strategic Career Planning

• Plan strategically when approaching the end of

funding and need for new application or renewal

– Conserve resources – Discuss, identify, request sources of bridging funds

• Ensure protected time or assistance to achieve

goals (if you don’t ask you will not receive)

– Time to write/complete publications and grants – Obtain preliminary data (time, resources, staff) – Ask for relief from non-essential activities/committees

• Consult with program officers (and others) for

guidance on unfunded grants and response to summary statement in a revision

• Apply to foundations for funding

9

ORCD Achieving Research Independence, P. Kay Lund, PhD

New Alternate Funding Sources

OnPar provides innovative and exceptional research applications with a second opportunity for funding.

– Applicants: submit their highly scored unfunded applications to OnPAR – Members: review research projects and select those that match their research priority areas for potential partnering/funding. – Partners: manage the review process of research applications that are submitted to OnPAR.

https://onpar.leidosweb.com 10

ORCD Achieving Research Independence, P. Kay Lund, PhD

Long-term, constant exciting discoveries (own and the field) Flexible and rewarding positions in academics and other research careers A family of former trainees, mentees across the USA and beyond Amazing rewards of their achievements Writing a grant is itself a reward (& fun)

• Immersion and expertise in the topic
• Focus on more than the $$

Science Academics Mentees Yes! Funding

Remember and Emphasize Biomedical Research Career Positives

11

ORCD Achieving Research Independence, P. Kay Lund, PhD

ORCD Achieving Research Independence, P. Kay Lund, PhD

12

New Clinical Trials Policy

13 NIH Definition of a Clinical Trial A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.

• Applications/proposals involving clinical trials with due dates on or after January 25,

2018 must be submitted to a funding opportunity announcement (FOA) or request for proposal (RFP) that explicitly states it will accept clinical trials.

• All existing FOAs will be updated with the following changes:
• All clinical trial FOAs will specify allowability of clinical trials in the FOA title (required,

not allowed, optional)

• FOAs will specify the allowability of clinical trials in Section II. Award Information
• FOAs that accept clinical trials will incorporate specific review criteria to ensure that

reviewers appropriately consider clinical trial-related information

• https://grants.nih.gov/policy/clinical-trials/definition.htm
• K awards permit independent clinical trials – apply to the correct FOA
• T/F awards permit mentored ‘clinical trials research experience’ but not independent

clinical trials led by trainee or fellow

ORCD Achieving Research Independence, P. Kay Lund, PhD

Request an Extension of ESI Status

§ PD/PIs may experience a lapse in their research or research training or have circumstances that necessitate less than full-time effort during their ESI status. § The NIH will consider requests to extend ESI status for medical concerns, disability, family care responsibilities, extended periods of clinical training, natural disasters, and active duty military service. § Extensions are determined on a case by case basis at the discretion of NIH. § ESIs may request an extension of their eligibility under existing ESI procedures (NOT-OD-09-034) described in the Extension Request Form.

ORCD Achieving Research Independence, P. Kay Lund, PhD

14

Compare Funding & Success Rates

• Success rates
• The percentage of reviewed grant applications which receive funding.
• Computed on a fiscal year basis and include applications that are peer reviewed and either scored or

unscored by an Initial Review Group.

• Determined by dividing the number of competing applications funded by the sum of the total number of

competing applications reviewed.

• Funded grants, which had one or more submissions for the same project in the same fiscal year, are only

counted once.

• Funding rates
• Person-based rather than application-based statistic
• Higher than success rate
• Counts applicants as funded whether they receive one or multiple awards in the same fiscal year.
• The numerator is the number of applicants receiving any funding that fiscal year
• The denominator is the number of applicants for that fiscal year.
• Funding rates, which are higher than success rates, paint a more promising picture for your prospects of

receiving NIH funding.

ORCD Achieving Research Independence, P. Kay Lund, PhD

15

Grants and Funding

16

http://grants.nih.gov/grants/oer.htm

§ Find Funding: NIH Guide for Grants and Contracts § How to Apply: Due Dates, Submission Policies, Prepare to Apply and Register, Format and Write, Submission Process § Explore NIH Funded Research - Research Portfolio Online Reporting Tools (RePORT)

ORCD Achieving Research Independence, P. Kay Lund, PhD

Applications for R21 have increased dramatically leading to reduced funding rates

https://nexus.od.nih.gov/all/2018/03/07/how-many-researchers- revisited-a-look-at-cumulative-investigator-funding-rates,

ORCD Achieving Research Independence, P. Kay Lund, PhD

17